Efficacy and Safety of Botulinum Toxin Type A for Moderate to Severe Crow's Feet Lines
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
This study will confirm the efficacy and safety of a single topical administration of
botulinum toxin type A compared to placebo control for the treatment of moderate to severe
crow's feet lines
Phase:
Phase 2
Details
Lead Sponsor:
Revance Therapeutics, Inc.
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA